Imatinib attenuates reperfusion injury in a rat model of acute myocardial infarction.

Authors:
Konijnenberg LSF; Luiken TTJ; Veltien A; Uthman L; Kuster CTA and 7 more

Journal:
Basic Res Cardiol

Publication Year: 2023

DOI:
10.1007/s00395-022-00974-z

PMCID:
PMC9839396

PMID:
36639597

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Basic Res Cardiol

Abbreviation: Basic Res Cardiol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Cardiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Acute antiarrhythmic effects of SGLT2 inhibitors-dapagliflozin lowers the excitability of atrial ca…
Paasche A; Wiedmann F; Kraft M and 16 more (2024) - Transparency Score: 3/6
Macrophage-based therapeutic approaches for cardiovascular diseases.
Sansonetti M; Al Soodi B; Thum T and 1 more (2024) - Transparency Score: 3/6
Pinacidil ameliorates cardiac microvascular ischemia-reperfusion injury by inhibiting chaperone-med…
Liu M; Li S; Yin M and 13 more (2024) - Transparency Score: 3/6
Activation of the integrated stress response rewires cardiac metabolism in Barth syndrome.
Kutschka I; Bertero E; Wasmus C and 22 more (2023) - Transparency Score: 3/6
Electrophysiological and calcium-handling development during long-term culture of human-induced plu…
Seibertz F; Sutanto H; Dülk R and 19 more (2023) - Transparency Score: 5/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestThe authors declare that they have no conflict of interest. Ethical approvalThe manuscript does not contain clinical studies or patient data. Animal experiments are performed conform the guidelines from Directive 2010/63/EU of the European Parliament and reported according to the ARRIVE guidelines. Conflict of interest The authors declare that they have no conflict of interest."

Evidence found in paper:

"Funding AA is supported by a European Research Council (ERC) Advanced Investigator grant (H2020-ERC-2017-ADV-788982-COLMIN) and by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) (VI.Veni.192.094)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025